Divi Towers
1-72/23(P)/DIVIS/303 Cyber Hills Gachibowli
Hyderabad 500032
India
91 40 6696 6300
https://www.divislabs.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm | CEO & Whole-Time Director | 247,9M | S.O. | 1976 |
Mr. L. Kishore Babu B.Com, FCMA, FICWA | Chief Financial Officer | S.O. | S.O. | 1952 |
Mr. M. Satish Choudhury | Company Secretary & Compliance Officer | S.O. | S.O. | S.O. |
Mr. Venkata Ramana Nimmagadda B.Sc.(Chem) | Executive Director | 363,1M | S.O. | 1958 |
Dr. Murali Krishna Prasad Divi M. Pharm, Ph.D. | MD & Executive Director | 704,9M | S.O. | 1951 |
Ms. Nilima Prasad Divi | Whole-time Director, Chief Control Officer & Director of Commercial | 246,4M | S.O. | 1983 |
Mr. L. Ramesh Babu LLB, M.Com, MBA | VP of Procurement & Chief Information Officer | S.O. | S.O. | 1957 |
Mr. Satya Prakash Divi B.Tech (Mech), MBA, MS (CIS) | Vice President of Sales & Marketing | S.O. | S.O. | 1977 |
Dr. S. Devendra Rao M.Sc. | Whole-Time Director (Manufacturing) | S.O. | S.O. | 1962 |
Mr. Y. T. S. Prasad B.E. | Global Quality Head | S.O. | S.O. | 1969 |
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
L’ISS Governance QualityScore de Divi's Laboratories Limited en date du 29 juin 2024 est 4. Les scores principaux sont Audit : 10; Société : 2; Droits des actionnaires : 1; Compensation : 1.